(RTTNews) - Shares of ObsEva SA (OBSV) were gaining around 8 percent in the morning trading in Switzerland after the clinical-stage biopharmaceutical company announced Wednesday additional positive ...

ObsEva SA (NASDAQ:OBSV), a US$651.8m small-cap, is a healthcare company operating in an industry, which continues to endure a more demanding healthcare agenda, and the global need for innovative, cost ...

One stock that might be an intriguing choice for investors right now is ObsEva SA OBSV. This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings estimate ...

ObsEva (NASDAQ:OBSV) stock is soaring higher on Friday despite there not being any noteworthy news today. To go along with the increase in price, shares of OBSV stock are also experiencing heavy ...

Stay at the forefront of the week’s champions and runners-up among publicly traded biotech companies and the reasons behind the ups or downs of their stock price fluctuations. StockWatch appears ...

A look at the shareholders of ObsEva SA (NASDAQ:OBSV) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a ...

In this article we will check out the progression of hedge fund sentiment towards ObsEva SA (NASDAQ:OBSV) and determine whether it is a good investment right now. We at Insider Monkey like to examine ...

Shares of ObsEva gained 22% in premarket trading on the news that the company' s experimental treatment for women with uterine fibroids met its primary and secondary endpoints in a Phase 3 trial. The ...

OBSEVA SA ACT NOM by ObsEva SA issues dividends to shareholders from excess cash OBSEVA SA ACT NOM by ObsEva SA generates. Most companies pay dividends on a quarterly basis, but dividends may also be ...

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors ...